Detalles de la búsqueda
1.
PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients.
Breast Cancer Res
; 16(1): R13, 2014 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-24467828
2.
Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment.
Breast Cancer Res
; 16(1): R6, 2014 Jan 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-24447434
3.
Urinary granzyme A mRNA is a biomarker to diagnose subclinical and acute cellular rejection in kidney transplant recipients.
Kidney Int
; 78(10): 1033-40, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20720522
4.
Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
Br J Haematol
; 145(3): 334-43, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19245431
5.
Expression of the polycomb-group gene BMI1 is related to an unfavourable prognosis in primary nodal DLBCL.
J Clin Pathol
; 60(2): 167-72, 2007 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-16837630
6.
Expression of the apoptosis inhibitor protease inhibitor 9 predicts clinical outcome in vaccinated patients with stage III and IV melanoma.
Clin Cancer Res
; 11(17): 6400-7, 2005 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16144945
7.
Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer.
Sci Rep
; 6: 18517, 2016 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26729235
8.
BRCA1-like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potential.
Mol Oncol
; 9(8): 1528-38, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26004083
9.
T-cell response in B-cell lymphomas: favorable or unfavorable?
Clin Cancer Res
; 14(8): 2514; author reply 2515-6, 2008 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18413849
10.
Apoptosis resistance and response to chemotherapy in primary nodal diffuse large B-cell lymphoma.
Hematol Oncol
; 24(3): 97-104, 2006 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16715473
11.
Human soluble TRAIL/Apo2L induces apoptosis in a subpopulation of chemotherapy refractory nodal diffuse large B-cell lymphomas, determined by a highly sensitive in vitro apoptosis assay.
Br J Haematol
; 134(3): 283-93, 2006 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16848771
12.
Inhibition of caspase 9 and not caspase 8 mediated apoptosis may determine clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas.
Cell Cycle
; 4(4): 526-8, 2005 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15876872
13.
High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis.
J Pathol
; 206(3): 328-36, 2005 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-15887291
14.
Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas.
Blood
; 105(7): 2916-23, 2005 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15576477
15.
Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?
Blood
; 99(1): 232-7, 2002 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11756176
Resultados
1 -
15
de 15
1
Próxima >
>>